Skip to main content
Syncona Limited logo

Syncona Limited — Investor Relations & Filings

Ticker · SYNC ISIN · GG00B8P59C08 LEI · 213800X8MBI5VQITLW60 IL Financial and insurance activities
Open in API
Filings indexed 1,029 across all filing types
Latest filing 2025-04-24 Regulatory Filings
Country GG Guernsey
Listing IL SYNC

About Syncona Limited

https://www.synconaltd.com/

Syncona Limited is a life science investment company focused on founding, building, and funding a portfolio of healthcare businesses. The company's strategy is to identify and advance exceptional science to create globally leading companies capable of delivering transformational treatments to patients, particularly in areas with high unmet medical needs. Its portfolio is concentrated in innovative therapeutic areas, including gene therapy, cell therapy, and biologics. Syncona actively manages its companies to reach key value inflection points, aiming to generate significant long-term capital appreciation for shareholders through strategic events such as mergers, acquisitions, and other liquidity events.

Recent filings

Filing Released Lang Actions
Mosaic Therapeutics update
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement issued by Syncona Limited regarding a portfolio company, Mosaic Therapeutics, in-licensing clinical-stage assets from Astex Pharmaceuticals. This is a corporate announcement regarding business development and M&A-related activity (in-licensing). While it involves M&A-like activity, it is primarily a regulatory announcement disseminated via RNS. Given the specific categories provided, 'RNS' serves as the appropriate fallback for general regulatory announcements that do not fit into more specific categories like 'TAR' (which is typically reserved for formal merger/takeover bids).
2025-04-24 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from Syncona Limited regarding the purchase of its own shares (share buyback) on the London Stock Exchange. It provides specific details such as the date of purchase, the number of shares, the price paid, and the resulting impact on total voting rights. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-04-23 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states the subject matter is a 'Transaction in Own Shares' and details the purchase of 100,000 ordinary shares as part of a 'share buyback programme'. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers company repurchases. The presence of an RNS Number and the reference to the London Stock Exchange further confirms it is a regulatory disclosure, but the specific content points overwhelmingly to POS.
2025-04-22 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from Syncona Limited detailing the purchase of its own shares (share buyback) on 16 April 2025. It provides specific details on the number of shares purchased, the price paid, and the resulting impact on treasury shares and total voting rights. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-04-17 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from Syncona Limited regarding the purchase of its own shares (share buyback) through a program announced in 2023. It provides specific details on the number of shares purchased, the price paid, and the resulting impact on treasury shares and total voting rights. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-04-16 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from Syncona Limited regarding the purchase of its own shares (share buyback) on the London Stock Exchange. It provides specific details on the number of shares purchased, the price paid, and the impact on total voting rights. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-04-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.